Real-time enrollment status for this newly diagnosed glioblastoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 8:45 AM UTC
| NCT Number | NCT04903795 |
| Recruiting Status | Recruiting |
| Condition | Newly Diagnosed Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mustafa Khasraw, MBChB, MD, FRCP, FRACP |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 2, 2026: Clinical trial NCT04903795 is currently recruiting participants. This phase1 study for newly diagnosed glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mustafa Khasraw, MBChB, MD, FRCP, FRACP. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04903795 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04903795 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.